George Simeon Email

CEO . Curevo Vaccine

Current Roles

Employees:
50
Revenue:
$7.8M
About
Curevo will combine excellence in protein science and adjuvant technology to speed safe and highly effective vaccines from the bench through clinical development. Curevo will focus on vaccine-preventable illnesses that are common in both the Asian and US markets and for which current vaccine products are not available. Curevo’s goal is to rapidly advance innovative new vaccine candidates from research laboratory to clinic by joining forces with South Korean Mogam Institute for Biomedical Research, GC Pharma, and the Infectious Disease Research Institute based in Seattle, Washington.
Curevo Vaccine Address
21540 30th Dr SE
Seattle, WA
United States
Curevo Vaccine Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.